Today, Arcam AB, listed on the NASDAQ OMX Stockholm, has announced a new generation of production grade 3D printers, specifically for the manufacture of medial implants. The Arcam Q10, is a new Electron Beam Melting (EBM) system for the industrial production of orthopedic implants.
The Arcam Q10 has been developed in close collaboration with leading implant manufacturers and partly financed by Vinnova. According the Arcam, “The system is designed to meet the implant industry’s need for ease of use, productivity, accuracy and quality assurance. The Arcam Q10 replaces the Arcam A1, the current industry standard for additive manufacturing of orthopedic implants.”
The orthopedic market is one of Arcam’s two main markets. EBM technology has been used specifically for implant production since 2007, and more than 30,000 EBM-manufactured orthopedic devices have been implanted worldwide since then. Furthermore, the market share of EBM-manufactured implants is continuing growing steadily and will likely increase with this latest development.
Arcam Q10 includes several new features for industrial volume production, including increased productivity, higher accuracy, and Arcam LayerQam™, a new camera based monitoring system for continuous quality assurance.
Magnus René, CEO of Arcam commented: “With the Arcam Q10 we sharpen our offering to one of our main markets, the implant industry. Arcam Q10 represents a new EBM generation, with a focus on continued industrialization of the technology. Arcam Q10 strengthens our already strong product program for orthopedic implants, a market that puts high demands on both the technology and the application expertise. The first Arcam Q10 user will be DiSanto Technology Inc. in Shelton, CT, USA, with whom we recently signed a strategic cooperation agreement.”